Psoriasis Treatment Market Projected to be Resilient by 2026 With Cipla Ltd., Novartis AG., Johnson & Johnson, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd.
There are five main types of psoriasis namely Plaque, Guttate, Inverse, Pustular, and Erythrodermic. Plaque psoriasis, also known as psoriasis vulgaris, is the most prevalent type of psoriasis, accounting for around 90% of reported cases. Most commonly affected areas of the body include back of the forearms, shins, around the navel, and the scalp. Guttate psoriasis has drop-shaped lesions. Pustular psoriasis is characterized by the presence of small non-infectious pus-filled blisters. Inverse psoriasis forms red patches in skin folds. Erythrodermic psoriasis occurs when the rash become widespread and can develop from other types. Fingernails and toenails are affected in most people at some point of time. This may include pits in the nails or changes in nail color.
Download PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/99
Treatment options for Psoriasis fueling growth of the psoriasis treatment market
Various treatments can help control the symptoms fueling growth of psoriasis treatment market. These treatment methods include administering steroid, vitamin D3, exposure to ultraviolet B (UVB) light, and immunosuppressive like methotrexate. Around 75% of cases can be managed with creams alone. Cream and ointments of corticosteroid, and calcipotriol can effectively treat mild-to-moderate psoriasis. However, when condition become more severe, creams are combined with oral medications such as methotrexate, acitretin, and cyclosporin.
Topical drugs used in treatment of psoriasis include corticosteroids, vitamin D, hydroxyanthrone, and retinoid aiding in growth of the psoriasis treatment market. Topical corticosteroids are frequently prescribed for treating mild-to-moderate psoriasis. Low-potency corticosteroid ointments are recommended for sensitive areas such as face or skin folds and for treating widespread patches of damaged skin. Medicated foams and scalp solutions are available in market to treat psoriasis patches on the scalp. Vitamin D analogues are synthetic forms of vitamin D and they slow the growth of skin cells. Calcipotriene (Dovonex) is a cream or solution a vitamin D that contains analogue, used by itself to treat mild-to-moderate psoriasis or in combination with other topical medications. Anthralin (Hydroxyanthrone) is used to normalize DNA activity in skin cells. Anthralin (Dritho-Scalp) also can remove scale, making the skin smoother. Topical retinoids normalizes DNA activity in skin cells and decreases inflammation.
Light Therapy (Phototherapy) for psoriasis treatment:
This psoriasis treatment involves use of natural or artificial ultraviolet light. Phototherapy involves exposing skin to controlled amounts of natural sunlight. Other forms of light therapy include use of artificial ultraviolet A (UVA) or ultraviolet B (UVB) light either alone or in combination with medications.
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/99
Increasing prevalence of psoriasis coupled with early diagnosis to propel growth of psoriasis treatment market
The growth of psoriasis treatment market is projected to gain traction in North America owing to large patient pool in this region. Also, better medical facilities, commercialization of new diagnostic technology, medical policies, and favorable reimbursement policies are factors fueling growth of psoriasis treatment market. According to the International Federation of Psoriasis Associations (IFPA), around 3% of the world’s population has some form of psoriasis. According to a study published in Cleveland Clinic in September 2013, there are around 150,000 new cases of psoriasis reported each year in the U.S. According to a study published in Medical Journal of Malaysia, in 2015 prevalence of psoriasis varies between 2.0% to 3.0% worldwide. Incidence rate is highest among Caucasians and lowest among Japanese and Africans. The study states that prevalence rate of psoriasis in Japan is 0.05% to 0.1%, as compared to China 0.5% and Taiwan 0.2%, and in India, the prevalence of psoriasis was reported in the range of 0.4% to 2.8%. High prevalence and increasing incidence propels growth of the psoriasis treatment market.
Key players involved in psoriasis treatment market:
There are many global players operating in the global psoriasis treatment market. This includes;
• Glenmark Pharmaceuticals Limited
• Sun Pharmaceuticals Industries Ltd.
• Cipla Ltd.
• Johnson & Johnson
• Rowan Bioceuticals Private Limited
• Stiefel Laboratories Inc. (GlaxoSmithKline plc)
• Win Medicare Pvt. Ltd.
• Novartis AG.
Novartis AG acquired Ziarco Pharma Ltd— a U.K.-based dermatology therapeutics firm—in December 2016 to acquire a pipeline of oral and topical products for treatment of psoriasis. Acquisition of the potentially first-in-class therapy would bolster dermatology portfolio and pipeline of Novartis. Ziarco completed Phase II trial, a proof-of-concept study with ZPL-389.
Grab Your Report at an Impressive Discount @ https://www.coherentmarketinsights.com/insight/request-discount/99
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psoriasis Treatment Market Projected to be Resilient by 2026 With Cipla Ltd., Novartis AG., Johnson & Johnson, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd. here
News-ID: 1442594 • Views: 1366
More Releases from Coherent Market Insights - Biotechnology
Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 …
Coherent Market Insights published a report, titled,"Wearable Patch Market, by Technology (Connected and Regular), by Application (Monitoring, Drug Delivery, and Diagnostics), by End User (Healthcare and Fitness & Sports), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027." Wearable patches are used for monitoring and diagnosis of chronic diseases. Increasing prevalence of diseases such as atrial
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy
More Releases for Psoriasis
Psoriasis Treatment Market - Innovations & Future Market Trends
Psoriasis is non-communicable autoimmune inflammatory, chronic, and painful skin disease characterized by abnormal skin patches. These skin patches are scaly, red, and itchy. These patches may be small and either localized or encompass the entire body. At present, there is no cure for this disease and the major goal of treatment is to limit inflammation and formation of abnormal skin plaque. Factors such as rising disease prevalence, significant unmet
Latest pipeline Psoriasis Market Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H2 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape. Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up skin, itchiness, and burning sensation, swollen and stiff joints. Predisposing factors include heredity, side effects of certain medicines, stress, infections and environmental conditions. The
Global Psoriasis Industrial and Market Analysis with Focus on Plaque Psoriasis: …
"Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed
Psoriasis Treatment Market: Analysis & Trends 2024
Global Psoriasis Treatment Market - Overview This report on the Psoriasis Treatment market analyzes the current and future scenario of the global market. Approval of new biologics, increase in access for the treatment in developing market, increase in the number of psoriasis patients, are boosting the growth of the global Psoriasis Treatment market. Increase in the incidence of Psoriasis and skin disorders, and novel pipeline drugs are some of the factors
Psoriasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Psoriasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H1 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape. Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It